Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include common findings: Deep venous thrombosis and Pulmonary embolism. 3 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 1 | Pulmonary embolism |
THBD function has not been fully characterized.
Thrombomodulin-related bleeding disorder has limited evidence linking it to mutations in the THBD gene on chromosome 20.
Genetic testing for THBD is available. Testing is considered research-grade for diagnosis.
Biomarker and diagnostic research for thrombomodulin-related bleeding disorder has been reported in the published literature.
Phenotype severity distribution: 2 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for thrombomodulin-related bleeding disorder.
136 publications have been identified in PubMed for thrombomodulin-related bleeding disorder. Research spans Review / Meta-Analysis (66%), Epidemiology / Natural History (14%), and Basic Science / Preclinical (9%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 78 | 66% |
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 7:40 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression
17 |
14% |
Laboratory research | 11 | 9% |
Other research | 4 | 3% |
Testing and diagnosis research | 3 | 3% |
Patient case studies | 3 | 3% |
Clinical study results | 3 | 3% |
Castaman G (2026). [PMID: 41496701](https://pubmed.ncbi.nlm.nih.gov/41496701/). *Haematologica*. [Review / Meta-Analysis]
Munekata Y (2026). [PMID: 41568992](https://pubmed.ncbi.nlm.nih.gov/41568992/). *Clin Appl Thromb Hemost*. [Basic Science / Preclinical]
Franchini M (2026). [PMID: 39904369](https://pubmed.ncbi.nlm.nih.gov/39904369/). *Semin Thromb Hemost*. [Review / Meta-Analysis]
Reardon B (2026). [PMID: 41750305](https://pubmed.ncbi.nlm.nih.gov/41750305/). *Biomolecules*. [Review / Meta-Analysis]
Iba T (2026). [PMID: 41843129](https://pubmed.ncbi.nlm.nih.gov/41843129/). *Inflamm Res*. [Review / Meta-Analysis]
Özer E (2026). [PMID: 41074491](https://pubmed.ncbi.nlm.nih.gov/41074491/). *Int J Gynaecol Obstet*. [Epidemiology / Natural History]
Salazar E (2026). [PMID: 42140677](https://pubmed.ncbi.nlm.nih.gov/42140677/). *Clin Lab Med*. [Review / Meta-Analysis]
Takahashi K (2026). [PMID: 41448542](https://pubmed.ncbi.nlm.nih.gov/41448542/). *J Thromb Haemost*. [Clinical Trial Publication]
Abu-Hanna J (2026). [PMID: 41607355](https://pubmed.ncbi.nlm.nih.gov/41607355/). *Transfusion*. [Review / Meta-Analysis]
Raghavan N (2026). [PMID: 41700516](https://pubmed.ncbi.nlm.nih.gov/41700516/). *Transfusion*. [Review / Meta-Analysis]